Liesbeth Reneman

Developmental Neuropsychopharmacology and Brainimaging group

Focus of research:

The Developmental Neuropsychopharmacology and Brainimaging group aims at unravelling the effects of drugs (of abuse) on the (developing) brain using a multidisciplinary approach and state-of-the-art neuroimaging techniques.

AMC themes: Neurological & Psychiatric Disorders
Departments: Radiology

Researchers:

AnneKlomp_AgeBYtreatmentEffectsRatphMRI_AfterFluoxetine

Anne Klomp

Effects of SSRIs on the (late) developing brain

Read more →

logotwitter

Anne Marije Kaag

The role of the serotonergic system in the development and treatment of cocaine dependence

Read more →

SchranteeAnouk_phMRI_AMPHMPH

Anouk Schrantee

Validating non-invasive imaging of the serotonergic and dopaminergic system and adult neurogenesis with MRI

Read more →

BouzianeCheima_Neurotransmitters

Cheima Bouziane

effects of psychotropic drugs on the developing brain (ePOD)

Read more →

logo-lebic_researcher_150x150

Hyke Tamminga

effects of psychotropic drugs on the developing brain (ePOD)

Read more →

logo-lebic_researcher_150x150

Maik Derksen

Validation of pharmacological MR imaging in awake rodents

Read more →

MariekeSchouw_freesurferbrainsegmentation

Marieke Schouw

Effects of Methylphenidate on the Developing Brain

Read more →

logo-lebic_researcher_150x150

Michiel de Ruiter

Neuroimaging of cognitive decline in cancer patients and cancer survivors

Read more →

KempermanMyrle_connectlogo

Myrle Kemperman

CONNECT

Read more →

MenningSanne_prospect

Sanne Menning

Structural, biochemical and functional indices of chemotherapy-induced cognitive deficits in breast cancer patients.

Read more →

Key publications

Klomp A, Tremoleda JL, Wylezinska M, Nederveen AJ, Feenstra M, Gsell W, Reneman L, Lasting effects of chronic fluoxetine treatment on the late developing rat brain: age-dependent changes in the serotonergic neurotransmitter system assessed by pharmacological MRI. NEUROIMAGE 2012;59 (1):218-226

de Ruiter MB, Reneman L, Boogerd W, Veltman DJ, Caan M, Douaud G, Lavini C, Linn SC, Boven E, van Dam FSAM, Schagen SB, Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: Converging results from multimodal magnetic resonance imaging. HUM BRAIN MAPP 2012;ahead of print

Homberg JR, Olivier JDA, Blom T, Arentsen T, van Brunschot C, Schipper P, Korte-Bouws G, van Luijtelaar G, Reneman L, Fluoxetine Exerts Age-Dependent Effects on Behavior and Amygdala Neuroplasticity in the Rat. PLOS ONE 2011;6 (1):e16646

Reneman L, Lavalaye J, Schmand B, de Wolff FA, van den Brink W, den Heeten GJ, Booij J, Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or “ecstasy”): preliminary findings. ARCH GEN PSYCHIAT 2001;58 (10):901-906

Reneman L, Booij J, de Bruin K, Reitsma JB, de Wolff FA, Gunning WB, den Heeten GJ, van den Brink W, Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons. LANCET 2001;358 (9296):1864-1869